NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Waltz was under pressure after a journalist was mistakenly added to a group chat in which senior officials were discussing military strikes.Read More